InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: GVX808 post# 11772

Monday, 10/12/2020 8:26:52 PM

Monday, October 12, 2020 8:26:52 PM

Post# of 16706
If we get good data from the Covid trial it's been stated that the path is to sell their rights. A fairly low cost addition to Solutions for Covid conditions and after effects. Then going forward with CC/NASH/IBD/CKD. I'm PRETTY SURE EVERYONE wants to get PAID and will let this run into initial news. See the StreetSmart interview. Raising again at $5+ for other repurposed drugs, BFD...
COVID patient Enrollments are progressing quickly and CEO says completed soon, data by mid Dec.
A $1B or $2B goes a long way with 200M fully diluted. Yea, I'll take shares as a partnership...GLTA...